Stay updated on Retinal Gene Therapy Clinical Trial for X-linked Retinitis Pigmentosa
Sign up to get notified when there's something new on the Retinal Gene Therapy Clinical Trial for X-linked Retinitis Pigmentosa page.

Latest updates to the Retinal Gene Therapy Clinical Trial for X-linked Retinitis Pigmentosa page
- Check3 days agoChange DetectedThe revision tag changed from v3.6.0 to v3.6.2, indicating a minor internal update. No user-visible content or functionality changes are observed on the page.SummaryDifference0.1%

- Check10 days agoChange DetectedThe Study Documents section no longer provides links to the Statistical Analysis Plan and Study Protocol, along with related release notes and provider information, thereby removing access to essential methodological materials for the trial.SummaryDifference24%

- Check17 days agoChange DetectedRecruitment status is updated to indicate no participants are being sought, clarifying that enrollment is closed. The page adds new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study), updates the Intervention/Treatment label (removing the older Interventions / Treatment phrasing), and upgrades the revision from v3.5.5 to v3.6.0 to reflect these changes.SummaryDifference0.3%

- Check24 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, representing a minor update to the page's build/version. This change is a metadata-level update rather than a visible content modification.SummaryDifference0.0%

- Check32 days agoChange DetectedNo additions or deletions were provided for this page, so there are no text changes to report.SummaryDifference0.1%

- Check39 days agoChange DetectedNo additions or deletions are reported for this page.SummaryDifference0.1%

Stay in the know with updates to Retinal Gene Therapy Clinical Trial for X-linked Retinitis Pigmentosa
Enter your email address, and we'll notify you when there's something new on the Retinal Gene Therapy Clinical Trial for X-linked Retinitis Pigmentosa page.